Antibody-mediated rejection of the kidney after simultaneous pancreas-kidney transplantation.

Published

Journal Article

The prevalence, risk factors, and outcome of antibody-mediated rejection (AMR) of the kidney after simultaneous pancreas-kidney transplantation are unknown. In 136 simultaneous pancreas-kidney recipients who were followed for an average of 3.1 yr, 21 episodes of AMR of the kidney allograft were identified. Eight episodes occurred early (

Full Text

Duke Authors

Cited Authors

  • Pascual, J; Samaniego, MD; Torrealba, JR; Odorico, JS; Djamali, A; Becker, YT; Voss, B; Leverson, GE; Knechtle, SJ; Sollinger, HW; Pirsch, JD

Published Date

  • April 2008

Published In

Volume / Issue

  • 19 / 4

Start / End Page

  • 812 - 824

PubMed ID

  • 18235091

Pubmed Central ID

  • 18235091

Electronic International Standard Serial Number (EISSN)

  • 1533-3450

Digital Object Identifier (DOI)

  • 10.1681/ASN.2007070736

Language

  • eng

Conference Location

  • United States